Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-42,300
Closed -$3.34M 1715
2025
Q4
$3.34M Sell
42,300
-16,400
-28% -$1.3M 0.01% 688
2025
Q3
$4.84M Buy
58,700
+8,000
+16% +$630K 0.02% 520
2025
Q2
$4.08M Buy
50,700
+3,100
+7% +$239K 0.03% 503
2025
Q1
$3.82M Buy
+47,600
New +$3.96M 0.04% 499
2024
Q4
Sell
-33,600
Closed -$2.77M 1456
2024
Q3
$2.77M Hold
33,600
0.02% 516
2024
Q2
$2.36M Hold
33,600
0.02% 510
2024
Q1
$2.49M Buy
+33,600
New +$2.34M 0.03% 507

Other funds holding MET

LMR Partners's MET Position: Q2 2026 in Review

LMR Partners increased its MetLife (MET) stake by 9.5% in Q2 2026, buying an estimated $39.9K and bringing the position to 5,694 shares worth $482K. The position accounts for ﹤0.01% of the portfolio, ranked #1187.

LMR Partners first reported a position in MET in Q3 2015 and has held it in 16 quarters since. The position peaked at $2.79M in Q4 2022. 1,445 funds tracked by Wall St. Rank hold MET as of Q2 2026.

  • LMR Partners held 5,694 shares of MetLife worth $482K as of Q2 2026.
  • LMR Partners bought 495 MetLife shares in Q2 2026, an estimated $39.9K.
  • MetLife made up ﹤0.01% of LMR Partners's portfolio in Q2 2026, its #1187 holding.
  • LMR Partners first reported a position in MetLife in Q3 2015 and has held it in 16 quarters since.
  • LMR Partners's MetLife position peaked at $2.79M in Q4 2022.
  • 1,445 funds tracked by Wall St. Rank held MetLife as of Q2 2026.

Based on LMR Partners's 13F filing for Q2 2026, filed 14 Aug 2026.